“Women Helping Women” Luncheon A Great Success!
May 20, 2009
By Ana de Alba
Board member, Fresno County Women Lawyers
A call to action heard loud and clear in the legal community was answered last month during the Fresno County Women Lawyers’ “Women Helping Women” luncheon. The luncheon featured speakers Jenny Bates, Director of The Hacienda Drug/Alcohol Rehabilitation Center for Women and Deborah Torres, Director of Samaritan Women. The speakers shared stories of how their organizations help women who have been incarcerated get back on their feet. Those attending the luncheon were asked to donate career clothing, toiletries, postage stamps, and bus tokens to help these wonderful organizations improve the lives of the women they serve. Generating donations for both organizations, FCWL members took up the call to action and made the luncheon an amazing success.
Thoughts on Music: DRM, iTunes and the iPod
February 16, 2007
by Steve Jobs
www.apple.com
February 6, 2007: With the stunning global success of Apple’s iPod music player and iTunes online music store, some have called for Apple to “open” the digital rights management (DRM) system that Apple uses to protect its music against theft, so that music purchased from iTunes can be played on digital devices purchased from other companies, and protected music purchased from other online music stores can play on iPods. Let’s examine the current situation and how we got here, then look at three possible alternatives for the future.
Health Care vs. High-Tech in War over Obvious Patents?
January 14, 2007
by John Timmer
Ars Technica
It’s not often that Science contains an analysis penned by a lawyer. But the lawyer in question, Michael R. Samardzija of the M.D. Anderson Cancer Center’s Intellectual Property office, suggests that the US Supreme Court is weighing an issue that may pit parts of Science’s readership against each other. At issue are cases where a patent covers a development that is obvious, and the analysis suggests that while the health care industry (including biotech) likes the current system, high-tech firms such as chipmakers are finding it a barrier to innovation.